F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine
NYT Homepage
by Christina Jewett and Rebecca RobbinsFebruary 18, 2026
Moderna held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.
Verticals
newsgeneral
Originally published on NYT Homepage on 2/18/2026